Press release

Local Press Releases

Press release

Dapagliflozin Is Well Tolerated in Hospitalized COVID-19 Patients

Expanded results from the first-of-its-kind clinical trial explores the use of SGLT2 inhibitor for COVID-19 patients with hypertension
Published: Sunday, June 27, 2021
ada-a_comms_logo